Organogenesis Holdings Inc - Class A — Financial Statements (NASDAQ:ORGO) | MetaTrader

Open full chart

News

Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript

Organogenesis Holdings extends leases for Canton facilities through 2032

Coupang and Regencell among market cap stock movers on Friday

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision

Organogenesis stock rises after initiating FDA application for knee arthritis treatment

Organogenesis begins FDA rolling review for knee arthritis treatment

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)

After-hours movers: Ford Motor, PayPal, Planet Fitness and more

Organogenesis stock soars after FDA meeting clears path for ReNu BLA

Organogenesis to submit rolling BLA for knee osteoarthritis treatment

Organogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO)

Organogenesis director Nussdorf sells $1.59 million in shares